3. Antiretroviral treatment

3.1 Treatment status at recruitment, by CD4 and year
Tab12

3.2 Treatment status at recruitment, by HIV viral load and year
Tab13

3.3 Treatment status of participants under follow-up, by CD4 and year *
Tab14
* At the first CD4 assessment of the year


3.4 Treatment status of participants under follow-up, by HIV viral load and year *
Tab15
* At the first highestviral load assessment of the year

3.5 Participants under treatment by first, second and third regimen, median of the duration (days)
Tab16

3.6 The most frequent combinations on the reference date January 1st, 2015
Tab17

3.7 The most frequent initial regimens on the reference date January 1st, 2015
Tab18

3.7.1 The most frequent initial regimens on the reference date January 1st, 2014
3.7.1 The most frequent initial regimens on the reference date
3.7.2 The most frequent initial regimens on the reference date January 1st, 2013
Tab18

3.8 The most frequent second-line regimens on the reference date January 1st, 2015

3.8.1 The most frequent second-line regimens on the reference date January 1st, 2014
3.8.1 The most frequent second-line regimens on the reference date January 1st, 2014

3.8.2 The most frequent second-line regimens on the reference date January 1st, 2013
3.8.2 The most frequent second-line regimens on the reference date January 1st, 2013
.

3.8.3 The most frequent second-line regimens on the reference date January 1st, 2012
3.8.3 The most frequent second-line regimens on the reference date January 1st, 2012
.

3.9 The four most frequently discontinued regimens in 2014, by reason, number
Tab12

3.9.1 The four most frequently discontinued regimens in 2013, by reason, number
Tab12

3.9.2 The four most frequently discontinued regimens in 2012, by reason, number
Tab12

3.9.3 The four most frequently discontinued regimens in 2011, by reason, number
Tab12

3.9.4 The four most frequently discontinued regimens in 2010, by reason, number
Tab12